CHIRALNANOMAT Chiral Nanocluster Materials
- Coordinator
- Politechnika Wroclawska, Poland
- Runs
- 1 November 2025 to 31 October 2029
- Status
- Running
- EU funding
- €3.5m
- Total cost
- —
- Partners
- 16 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101227458
What the project is doing
In the project's own words, from its summary on CORDIS.
CHIRALNANOMAT is a multi-disciplinary DN project between 7 laboratories and 6 companies in 8 European countries. The networkmerges physics, chemistry, and biosciences into a unique combination of advanced synthesis and characterization of chiral metalnanoclusters, as well as their applications in catalysis and biosensing. CHIRALNANOMAT's innovative approach overcomes the currentstate-of-the-art through: (A) production of chiral atomically precise metal nanoclusters and their assemblies, (B) extensivecharacterization of their chiral properties, structure and optical properties; both in solution phase and on solid supports, (C) catalyticand biomedical applications followed by the prototyping of the most promising enantioselective catalysts and bioprobes, and (D)development of new computational tools to study chiroptical, catalytic properties and interface of nanomaterials and biomoleculesand integration of computational and experimental studies to understand their functionalities.
CHIRALNANOMAT will train 13 Doctoral Candidates who will become experts in chiral nanomaterials and will be able to answer to thefuture needs of academic and industrial sectors in Europe. By acquiring skills in chemical synthesis, spectroscopic methods, nonlinearsurface optics, surface science imaging and scanning probes, bio-functionalization, bio-imaging, and computational electronicstructure and molecular dynamics methods as well as machine learning for modeling, and being exposed to an intersectoralenvironment (through secondments and network-wide training) they will be competitive in future job markets in critical areas ofnanotechnology having impact, among others, on synthesis for production of drugs and fine chemicals and novel biotechnology enabledpersonalized nanomedicine.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Politechnika Wroclawska | Wroclaw | Poland | Coordinator |
| Invisible-Light Labs GmbH | Wien | Austria | Associatedpartner |
| Technische Universitaet Wien | Wien | Austria | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Universite De Geneve | Geneve | Switzerland | Associatedpartner |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Universite Lyon 1 Claude Bernard | Villeurbanne Cedex | France | Associatedpartner |
| Furukawa Electric Technologiai Intezet Korlatolt Felelossegu Tarsasag | Budapest | Hungary | Associatedpartner |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Icons SRL | Rovereto Tn | Italy | Associatedpartner |
| Universita Degli Studi Di Trieste | Trieste | Italy | Participant |
| Universita Di Pisa | Pisa | Italy | Associatedpartner |
| Software for Chemistry & Materials BV | Amsterdam | Netherlands | Participant |
| Stichting Vu | Amsterdam | Netherlands | Associatedpartner |
| NanoExpo spolka z ograniczona odpowiedzialnoscia | Gdansk | Poland | Associatedpartner |
| Prochimia Surfaces Sp. Z O.o. | Gdynia | Poland | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI